Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression.

Kamal MA, Gieschke R, Lemenuel-Diot A, Beauchemin CA, Smith PF, Rayner CR.

Antimicrob Agents Chemother. 2016 Feb 26;60(3):1953. doi: 10.1128/AAC.00179-16. Print 2016 Mar. No abstract available.

PMID:
26921415
Free PMC Article
2.

A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling.

van Schaick E, Zheng J, Perez Ruixo JJ, Gieschke R, Jacqmin P.

J Pharmacokinet Pharmacodyn. 2015 Aug;42(4):315-32. doi: 10.1007/s10928-015-9423-3. Epub 2015 Jun 30.

PMID:
26123920
3.

A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progression.

Kamal MA, Gieschke R, Lemenuel-Diot A, Beauchemin CA, Smith PF, Rayner CR.

Antimicrob Agents Chemother. 2015 Sep;59(9):5388-95. doi: 10.1128/AAC.00069-15. Epub 2015 Jun 22. Erratum in: Antimicrob Agents Chemother. 2016 Mar;60(3):1953.

4.

Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNI.

Delor I, Charoin JE, Gieschke R, Retout S, Jacqmin P.

CPT Pharmacometrics Syst Pharmacol. 2013 Oct 2;2:e78. doi: 10.1038/psp.2013.54.

5.

Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Carmichael O, Xie J, Fletcher E, Singh B, DeCarli C; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2012 Jun;33(6):1124.e31-41. doi: 10.1016/j.neurobiolaging.2011.08.016. Epub 2011 Dec 14.

6.

Detecting global and local hippocampal shape changes in Alzheimer's disease using statistical shape models.

Shen KK, Fripp J, Mériaudeau F, Chételat G, Salvado O, Bourgeat P; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Feb 1;59(3):2155-66. doi: 10.1016/j.neuroimage.2011.10.014. Epub 2011 Oct 14.

PMID:
22037419
7.

Individual subject classification for Alzheimer's disease based on incremental learning using a spatial frequency representation of cortical thickness data.

Cho Y, Seong JK, Jeong Y, Shin SY; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Feb 1;59(3):2217-30. doi: 10.1016/j.neuroimage.2011.09.085. Epub 2011 Oct 8.

PMID:
22008371
8.

BEaST: brain extraction based on nonlocal segmentation technique.

Eskildsen SF, Coupé P, Fonov V, Manjón JV, Leung KK, Guizard N, Wassef SN, Østergaard LR, Collins DL; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2012 Feb 1;59(3):2362-73. doi: 10.1016/j.neuroimage.2011.09.012. Epub 2011 Sep 16.

PMID:
21945694
9.

Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.

McEvoy LK, Holland D, Hagler DJ Jr, Fennema-Notestine C, Brewer JB, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

Radiology. 2011 Jun;259(3):834-43. doi: 10.1148/radiol.11101975. Epub 2011 Apr 6.

10.

Using CSF biomarkers to replicate genetic associations in Alzheimer's disease.

Schott JM; ADNI Investigators.

Neurobiol Aging. 2012 Jul;33(7):1486.e9-15. doi: 10.1016/j.neurobiolaging.2011.02.008. Epub 2011 Apr 3.

11.

Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.

Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW; Alzheimer's Disease NeuroImaging Initiative.

Brain. 2011 Apr;134(Pt 4):1077-88. doi: 10.1093/brain/awr044. Epub 2011 Mar 22.

12.

Fine mapping of genetic variants in BIN1, CLU, CR1 and PICALM for association with cerebrospinal fluid biomarkers for Alzheimer's disease.

Kauwe JS, Cruchaga C, Karch CM, Sadler B, Lee M, Mayo K, Latu W, Su'a M, Fagan AM, Holtzman DM, Morris JC; Alzheimer's Disease Neuroimaging Initiative, Goate AM.

PLoS One. 2011 Feb 9;6(2):e15918. doi: 10.1371/journal.pone.0015918.

13.

Exploring cell tropism as a possible contributor to influenza infection severity.

Dobrovolny HM, Baron MJ, Gieschke R, Davies BE, Jumbe NL, Beauchemin CA.

PLoS One. 2010 Nov 23;5(11):e13811. doi: 10.1371/journal.pone.0013811.

14.

Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study.

Dobrovolny HM, Gieschke R, Davies BE, Jumbe NL, Beauchemin CA.

J Theor Biol. 2011 Jan 21;269(1):234-44. doi: 10.1016/j.jtbi.2010.10.017. Epub 2010 Oct 21.

PMID:
20970433
15.

Interactive visualization and communication for increased impact of pharmacometrics.

Krause A, Gieschke R.

J Clin Pharmacol. 2010 Sep;50(9 Suppl):140S-145S. doi: 10.1177/0091270010376964.

PMID:
20881227
16.

Population pharmacokinetic/pharmacodynamic model for C.E.R.A. in both ESA-naive and ESA-treated chronic kidney disease patients with renal anemia.

Chanu P, Gieschke R, Charoin JE, Pannier A, Reigner B.

J Clin Pharmacol. 2010 May;50(5):507-20. doi: 10.1177/0091270009343931. Epub 2010 Feb 23.

PMID:
20179322
17.

Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, Dutkowski R, Hoffmann G, Breidenbach A, Lindemann L, Carey E, Boak L, Gieschke R, Sacks S, Solsky J, Small I, Reddy D.

Drug Saf. 2008;31(12):1097-114. doi: 10.2165/0002018-200831120-00006. Review.

PMID:
19026027
18.

Population pharmacokinetics of oseltamivir when coadministered with probenecid.

Rayner CR, Chanu P, Gieschke R, Boak LM, Jonsson EN.

J Clin Pharmacol. 2008 Aug;48(8):935-47. doi: 10.1177/0091270008320317. Epub 2008 Jun 4.

PMID:
18524996
19.

An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabetics.

Jauslin PM, Silber HE, Frey N, Gieschke R, Simonsson US, Jorga K, Karlsson MO.

J Clin Pharmacol. 2007 Oct;47(10):1244-55.

PMID:
17906159
20.

An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations.

Silber HE, Jauslin PM, Frey N, Gieschke R, Simonsson US, Karlsson MO.

J Clin Pharmacol. 2007 Sep;47(9):1159-71.

PMID:
17766701
Items per page

Supplemental Content

Loading ...
Write to the Help Desk